Publication | Closed Access

N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease

Gaucher DiseaseBiochemistryGlycosylationMedicineNatural SciencesGlycobiologyCellular BiochemistryPharmacologyCell BiologyF213i Mutant β-GlucosidaseN-octyl-β-valienamine Up-regulates Activity